Literature DB >> 26377866

Novel transferable erm(46) determinant responsible for emerging macrolide resistance in Rhodococcus equi.

Elisa Anastasi1, Steeve Giguère2, Londa J Berghaus3, Mary K Hondalus4, Jennifer M Willingham-Lane4, Iain MacArthur1, Noah D Cohen5, Marilyn C Roberts6, Jose A Vazquez-Boland7.   

Abstract

OBJECTIVES: The objective of this study was to identify the molecular mechanism of macrolide resistance in the actinomycete Rhodococcus equi, a major equine pathogen and zoonotic agent causing opportunistic infections in people.
METHODS: Macrolide-resistant (n = 62) and macrolide-susceptible (n = 62) clinical isolates of R. equi from foals in the USA were studied. WGS of 18 macrolide-resistant and 6 macrolide-susceptible R. equi was performed. Representative sequences of all known macrolide resistance genes identified to date were used to search the genome assemblies for putative homologues. PCR was used to screen for the presence of the identified resistance determinant in the rest of the isolates. Mating experiments were performed to verify mobility of the gene.
RESULTS: A novel erm gene, erm(46), was identified in all sequenced resistant isolates, but not in susceptible isolates. There was complete association between macrolide resistance and the presence of erm(46) as detected by PCR screening of all 124 clinical isolates of R. equi. Expression of erm(46) in a macrolide-susceptible strain of R. equi induced high-level resistance to macrolides, lincosamides and streptogramins B, but not to other classes of antimicrobial agents. Transfer of erm(46) to macrolide-susceptible R. equi was confirmed. The transfer frequency ranged from 3 × 10(-3) to 1 × 10(-2).
CONCLUSIONS: This is the first molecular characterization of resistance to macrolides, lincosamides and streptogramins B in R. equi. Resistance was due to the presence of a novel erm(46) gene mobilizable likely by conjugation, which has spread among equine isolates of R. equi in the USA.
© The Author 2015. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26377866     DOI: 10.1093/jac/dkv279

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  11 in total

1.  Effect of Macrolide and Rifampin Resistance on Fitness of Rhodococcus equi during Intramacrophage Replication and In Vivo.

Authors:  Jennifer M Willingham-Lane; Londa J Berghaus; Roy D Berghaus; Kelsey A Hart; Steeve Giguère
Journal:  Infect Immun       Date:  2019-09-19       Impact factor: 3.441

2.  Novel Quantitative PCR for Rhodococcus equi and Macrolide Resistance Detection in Equine Respiratory Samples.

Authors:  Sonsiray Álvarez Narváez; Ingrid Fernández; Nikita V Patel; Susan Sánchez
Journal:  Animals (Basel)       Date:  2022-05-03       Impact factor: 3.231

3.  Effect of Macrolide and Rifampin Resistance on the Fitness of Rhodococcus equi.

Authors:  Jennifer M Willingham-Lane; Londa J Berghaus; Roy D Berghaus; Kelsey A Hart; Steeve Giguère
Journal:  Appl Environ Microbiol       Date:  2019-03-22       Impact factor: 4.792

Review 4.  Epidemiology and Molecular Basis of Multidrug Resistance in Rhodococcus equi.

Authors:  Sonsiray Álvarez-Narváez; Laura Huber; Steeve Giguère; Kelsey A Hart; Roy D Berghaus; Susan Sanchez; Noah D Cohen
Journal:  Microbiol Mol Biol Rev       Date:  2021-04-14       Impact factor: 11.056

5.  Pangenome and Phylogenomic Analysis of the Pathogenic Actinobacterium Rhodococcus equi.

Authors:  Elisa Anastasi; Iain MacArthur; Mariela Scortti; Sonsiray Alvarez; Steeve Giguère; José A Vázquez-Boland
Journal:  Genome Biol Evol       Date:  2016-10-23       Impact factor: 3.416

6.  Clonal Confinement of a Highly Mobile Resistance Element Driven by Combination Therapy in Rhodococcus equi.

Authors:  Sonsiray Álvarez-Narváez; Steeve Giguère; Elisa Anastasi; Jack Hearn; Mariela Scortti; José A Vázquez-Boland
Journal:  mBio       Date:  2019-10-15       Impact factor: 7.867

7.  Spread of Multidrug-Resistant Rhodococcus equi, United States.

Authors:  Sonsiray Álvarez-Narváez; Steeve Giguère; Noah Cohen; Nathan Slovis; José A Vázquez-Boland
Journal:  Emerg Infect Dis       Date:  2021-02       Impact factor: 6.883

8.  International Spread of Multidrug-Resistant Rhodococcus equi.

Authors:  Jorge Val-Calvo; Jane Darcy; James Gibbons; Alan Creighton; Claire Egan; Thomas Buckley; Achim Schmalenberger; Ursula Fogarty; Mariela Scortti; José A Vázquez-Boland
Journal:  Emerg Infect Dis       Date:  2022-09       Impact factor: 16.126

9.  Antimicrobial Resistance Spectrum Conferred by pRErm46 of Emerging Macrolide (Multidrug)-Resistant Rhodococcus equi.

Authors:  Erdal Erol; Mariela Scortti; Jordan Fortner; Mukesh Patel; José A Vázquez-Boland
Journal:  J Clin Microbiol       Date:  2021-07-28       Impact factor: 5.948

10.  A Common Practice of Widespread Antimicrobial Use in Horse Production Promotes Multi-Drug Resistance.

Authors:  S Álvarez-Narváez; L J Berghaus; E R A Morris; J M Willingham-Lane; N M Slovis; S Giguere; N D Cohen
Journal:  Sci Rep       Date:  2020-01-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.